Skip to main content
Fig. 1 | Acta Neuropathologica Communications

Fig. 1

From: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Fig. 1

Prevalence of α-synuclein pathology in LRRK2 mutation carriers. Seven brain regions from 12 individuals carrying LRRK2 mutations were evaluated by staining for pathological pS129 α-synuclein (EP1536Y). Of the 12 cases, 7 showed prominent pathological α-synuclein throughout the brain, including the substantia nigra, while 5 cases had minimal pathological α-synuclein present. Scale bar = 100 μm

Back to article page
\